Press release
Castle Biosciences Celebrates Skin Cancer Awareness Month
The Company continues its ongoing partnerships with IMPACT Melanoma, AIM at Melanoma and Melanoma Research Foundation to drive education and awareness
About this update from Castle Biosciences, Inc.
[{"type":"text","content":"The Company continues its ongoing partnerships with IMPACT Melanoma, AIM at Melanoma and Melanoma Research Foundation to drive education and awareness throughout May Castle highlights cancer journey of melanoma survivor and advocate, Leah Adams A Media Snippet accompanying this announcement is available in this link. FRIENDSWOOD, Texas, May 07, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, is recognizing Skin Cancer Awareness Month this May by supporting a series of initiatives designed to raise awareness, educate patients and families and empower those impacted by skin cancer. “At Castle, our mission is rooted in delivering clinically actionable information to patients and their clinical care teams — and that begins with awareness and education,” said Derek Maetzold, president and chief executive officer of Castle Biosciences. “By supporting organizations like IMPACT Melanoma and sharing real patient stories like Leah’s, we aim to drive conversations around early detection and personalized risk assessment in an effort to help improve patient outcomes.” Empowering Patients and Caregivers: IMPACT Melanoma Virtual Patient SymposiumCastle is proud to continue its long-standing partnership with IMPACT Melanoma by sponsoring the organization’s upcoming virtual patient symposium, “Melanoma Diagnosis: A Toolkit to Support the Journey.” The event will be held on Wednesday, May 21, 2025, at 6 p.m. ET, and has been designed to provide individuals newly diagnosed with melanoma — and their support networks — with practical tools, resources and compassionate guidance to navigate the melanoma journey. Aaron Farberg, M.D., FAAD, double board-certified dermatologist, Mohs surgeon and chief medical officer of Bare Dermatology in Dallas, will lead the discussion, joined by dermatology interest group students Mitchell Hanson and Brianna Speigel. Topics will include navigating a diagnosis, emotional support resources, survivorship planning and how patients and caregivers can more effectively advocate for melanoma care. Registration details can be found here. “This symposium was created to meet people where they are — at a vulnerable moment in their lives,” said Deb Girard, executive director of IMPACT Melanoma. “We want everyone who attends, whether the...